We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$875M
AUM Growth
+$115M
Cap. Flow
+$78.2M
Cap. Flow %
8.94%
Top 10 Hldgs %
75.39%
Holding
137
New
24
Increased
29
Reduced
45
Closed
15

Top Buys

Rank Stock Value
1
AGGH icon
Simplify Aggregate Bond ETF
AGGH
+$52.7M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$37M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$5.71M
4
PAGP icon
Plains GP Holdings
PAGP
+$5.15M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$4.8M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$24.1M
2
PAA icon
Plains All American Pipeline
PAA
+$9.16M
3
CDX icon
Simplify High Yield ETF
CDX
+$3.85M
4
BUCK icon
Simplify Stable Income ETF
BUCK
+$2.81M
5
SVOL icon
Simplify Volatility Premium ETF
SVOL
+$2.74M

Sector Composition

Rank Sector Weight
1 Miscellaneous 85.14%
2 Healthcare 10.77%
3 Energy 2.53%
4 Financials 0.6%
5 Technology 0.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSAT icon
26
Telesat
TSAT
$683M
$3.73M 0.43%
260,781
+100,000
+62% +$1.36M
AMGN icon
27
Amgen
AMGN
$236B
$3.64M 0.42%
13,539
+12,170
+889% +$3.04M
REGN icon
28
Regeneron Pharmaceuticals
REGN
$85.2B
$3.54M 0.4%
4,302
+583
+16% +$458K
CRNX
29
DELISTED
Crinetics Pharmaceuticals
CRNX
$3.42M 0.39%
+115,000
New +$2.37M
BSX icon
30
Boston Scientific
BSX
$69.3B
$3.23M 0.37%
61,116
+49,304
+417% +$2.59M
SNY icon
31
Sanofi
SNY
$106B
$3.18M 0.36%
59,358
-21,455
-27% -$1.14M
AKRO
32
DELISTED
Akero Therapeutics
AKRO
$3.02M 0.35%
59,777
– –
LONA
33
LeonaBio Inc
LONA
$71.2M
$3.02M 0.34%
149,279
– –
TCRX icon
34
TScan Therapeutics
TCRX
$26.5M
$2.68M 0.31%
1,046,916
– –
LLY icon
35
Eli Lilly
LLY
$1.02T
$2.64M 0.3%
4,915
-1,274
-21% -$656K
CI icon
36
Cigna
CI
$74.7B
$2.61M 0.3%
9,107
+2,464
+37% +$703K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$138B
$2.58M 0.3%
7,425
-66
-0.9% -$23.1K
REPL icon
38
Replimune Group
REPL
$1.42B
$2.57M 0.29%
150,000
– –
ABBV icon
39
AbbVie
ABBV
$453B
$2.55M 0.29%
17,122
+4,308
+34% +$632K
FULC icon
40
Fulcrum Therapeutics
FULC
$294M
$2.53M 0.29%
570,519
-125,777
-18% -$550K
JNJ icon
41
Johnson & Johnson
JNJ
$663B
$2.52M 0.29%
16,165
-7,598
-32% -$1.25M
SAGE
42
DELISTED
Sage Therapeutics
SAGE
$2.47M 0.28%
120,030
+70,000
+140% +$2.02M
PHAT icon
43
Phathom Pharmaceuticals
PHAT
$769M
$2.47M 0.28%
237,935
– –
UNH icon
44
UnitedHealth
UNH
$356B
$2.41M 0.28%
4,785
+3,788
+380% +$1.86M
MDT icon
45
Medtronic
MDT
$120B
$2.31M 0.26%
29,466
-18,053
-38% -$1.51M
HARD icon
46
Simplify Commodities Strategy No K-1 ETF
HARD
$75.6M
$2.24M 0.26%
88,056
-43,297
-33% -$1.1M
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$6.15B
$2.21M 0.25%
70,000
– –
ISRG icon
48
Intuitive Surgical
ISRG
$130B
$2.17M 0.25%
7,421
+1,308
+21% +$408K
DAWN
49
DELISTED
Day One Biopharmaceuticals
DAWN
$2.15M 0.25%
+175,018
New +$2.28M
IBDP
50
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
– –
0
– –
1
2
3 4 5

Similar funds

CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $7.18B AUM 18.15% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
GT
Glenview Trust Louisville, Kentucky $7.23B AUM 27.68% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $7.25B AUM 33.76% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Simplify Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Simplify Asset Management held 137 positions worth $875M, up 15% from $760M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Simplify Asset Management deployed $78.2M of net new capital in Q3 2023, opening 24 new positions and adding to 29 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 49,900 shares worth $4.43M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 83% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $24.1M trimmed.

  • Simplify Asset Management's largest Q3 2023 buy was iShares 20+ Year Treasury Bond ETF: 49,900 shares worth $4.43M.
  • Simplify Asset Management added most to Simplify Aggregate Bond ETF in Q3 2023, an estimated $52.7M increase.
  • Simplify Asset Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $24.1M.
  • Simplify Asset Management fully exited Plains All American Pipeline in Q3 2023, selling an estimated $9.16M.
  • Simplify Asset Management's ten largest holdings make up 75% of its $875M portfolio in Q3 2023.
  • Simplify Asset Management opened 24 new positions and closed 15 in Q3 2023.
  • Simplify Asset Management's portfolio value rose 15% quarter-over-quarter to $875M.

Based on Simplify Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.